Sorrento Therapeutics Ink. (Seite 88)
eröffnet am 24.06.19 16:11:40 von
neuester Beitrag 29.05.24 20:54:23 von
neuester Beitrag 29.05.24 20:54:23 von
Beiträge: 1.317
ID: 1.306.128
ID: 1.306.128
Aufrufe heute: 14
Gesamt: 93.334
Gesamt: 93.334
Aktive User: 0
ISIN: US83587F2020 · WKN: A1W8DY · Symbol: SRNE
0,0110
USD
+10,00 %
+0,0010 USD
Letzter Kurs 02:10:00 Nasdaq OTC
Neuigkeiten
TitelBeiträge |
---|
12.09.23 · globenewswire |
07.09.23 · globenewswire |
27.07.23 · globenewswire |
05.07.23 · globenewswire |
Werte aus der Branche Biotechnologie
Wertpapier | Kurs | Perf. % |
---|---|---|
4,9600 | +41,71 | |
5,3000 | +28,64 | |
1,3000 | +26,21 | |
1,1000 | +22,22 | |
16,550 | +14,14 |
Wertpapier | Kurs | Perf. % |
---|---|---|
2,1200 | -18,46 | |
9,6000 | -18,64 | |
2,0850 | -19,19 | |
1,4600 | -24,56 | |
1,7000 | -31,17 |
Beitrag zu dieser Diskussion schreiben
Antwort auf Beitrag Nr.: 65.827.914 von Rolf1K am 24.11.20 18:33:14...hier hängt es vom News Flow ab, kann dauern oder auch nicht...
Antwort auf Beitrag Nr.: 65.825.271 von Charly_2 am 24.11.20 15:58:18
Die Info-Politik der meisten Firmen ist generell so, dass etwas Schlechtes nur zugegeben wird, wenn es nicht mehr zu verheimlichen ist. Das würde bedeuten, dass Moderna wahrscheinlich schon genau weiss, dass Geimpfte trotzdem ansteckend sind, der Hammer.
Aber der Kurs hier macht mich schon etwas unruhig. Hast du eine positive Erwartung?
Zitat von Charly_2: Moderna vermeldete heute dass man durch die Impfung geschützt sei aber unsicher ob man nicht trotzdem infektiös sein könne...
Ein Witz?
Die Info-Politik der meisten Firmen ist generell so, dass etwas Schlechtes nur zugegeben wird, wenn es nicht mehr zu verheimlichen ist. Das würde bedeuten, dass Moderna wahrscheinlich schon genau weiss, dass Geimpfte trotzdem ansteckend sind, der Hammer.
Aber der Kurs hier macht mich schon etwas unruhig. Hast du eine positive Erwartung?
Antwort auf Beitrag Nr.: 65.815.632 von Rolf1K am 23.11.20 22:08:03Moderna vermeldete heute dass man durch die Impfung geschützt sei aber unsicher ob man nicht trotzdem infektiös sein könne...
Ein Witz?
Ein Witz?
Es wird nicht funktionieren. Sollten die Impfstoffe tatsächlich wirken, werden dennoch die Infektionen steigen, sobald die Einschränkungen zurückgenommen werden. Und auch wenn Covid mutiert, oder wenn die Wirkung geringer als erhofft ist, sowieso. Irgendwann wird man die Therapeutika doch zulassen müsssen, wenn es nicht schon bald passiert.
Etwas Lesestoff
https://investors.sorrentotherapeutics.com/static-files/ca9b…
https://investors.sorrentotherapeutics.com/static-files/ca9b…
Neuer MF Beitrag :-)
https://www.fool.com/investing/2020/11/20/is-sorrento-therap…
Sorrento has perhaps the most plentiful COVID-19 pipeline, with at least eight different products in development.
Aktie müsste schon längstens über $20 stehen, wenn man Moderna sieht welche die MarketCap vervierfacht hat was ja krass überbewertet ist!
https://www.fool.com/investing/2020/11/20/is-sorrento-therap…
Sorrento has perhaps the most plentiful COVID-19 pipeline, with at least eight different products in development.
Aktie müsste schon längstens über $20 stehen, wenn man Moderna sieht welche die MarketCap vervierfacht hat was ja krass überbewertet ist!
Antwort auf Beitrag Nr.: 65.774.784 von Charly_2 am 19.11.20 20:54:20Ab Yahoo Board, von Robert:
https://finance.yahoo.com/quote/SRNE/community?p=SRNE
Did anyone watch the Motley Fool interview today with Dr. Ji and Dr. Brunswick? The free snippet did not provide much but the entire (paid Motley subscription) interview was about an hour. It pained me greatly to give Motley $99 of my money but the interview provided a lot of information and clarity regarding their pipeline, their competitors, and the latest vaccine news from Pfizer and Moderna.
The interviewer was fair, had solid questions, and allowed both men ample time to speak.
Of huge note to me was regarding COVI-TRACK. They explained that their original submission to the FDA was based on First Gen tech for serology antibody tests. There is no approval because they have told the FDA that they are going to submit Second Gen tech that greatly improves on sensitivity and specificity, hence accuracy. They stated that they HAVE NOT submitted the new second gen tech as of yet but that it was imminent. Date of actual interview recording was about a week ago.
Although they have a fairly large COVID pipeline, it's obvious (from both their corporate presentation released yesterday and today's Motley interview) that they now have a clear vision of how they want to integrate their diagnostic products with their line of treatments from early stages all the way to rescue and recovery treatments.
They have a solid vision for diagnostics, prevention, and early intervention and treatments that can all take place at home, your local pharmacy, or the doctor's office -- avoiding hospitalization altogether.
https://finance.yahoo.com/quote/SRNE/community?p=SRNE
Did anyone watch the Motley Fool interview today with Dr. Ji and Dr. Brunswick? The free snippet did not provide much but the entire (paid Motley subscription) interview was about an hour. It pained me greatly to give Motley $99 of my money but the interview provided a lot of information and clarity regarding their pipeline, their competitors, and the latest vaccine news from Pfizer and Moderna.
The interviewer was fair, had solid questions, and allowed both men ample time to speak.
Of huge note to me was regarding COVI-TRACK. They explained that their original submission to the FDA was based on First Gen tech for serology antibody tests. There is no approval because they have told the FDA that they are going to submit Second Gen tech that greatly improves on sensitivity and specificity, hence accuracy. They stated that they HAVE NOT submitted the new second gen tech as of yet but that it was imminent. Date of actual interview recording was about a week ago.
Although they have a fairly large COVID pipeline, it's obvious (from both their corporate presentation released yesterday and today's Motley interview) that they now have a clear vision of how they want to integrate their diagnostic products with their line of treatments from early stages all the way to rescue and recovery treatments.
They have a solid vision for diagnostics, prevention, and early intervention and treatments that can all take place at home, your local pharmacy, or the doctor's office -- avoiding hospitalization altogether.
Rakete gezündet?
https://www.fool.com/investing/2020/11/19/sorrento-ceo-henry…
https://www.fool.com/investing/2020/11/19/sorrento-ceo-henry…
Der Sorrento Test braucht auch die 30 Minuten wenn er jemals kommt.
https://www.fda.gov/news-events/press-announcements/coronavi…
https://www.fda.gov/news-events/press-announcements/coronavi…
Was nützt uns der Sorrento Test wenn er noch keine Zulassung hat? In der Theorie besser zu sein bringt uns nicht weiter nach oben. Wir brauchen endlich die FDA Zulassung damit die Rakete abhebt!
12.09.23 · globenewswire · Sorrento Therapeutics |
07.09.23 · globenewswire · Sorrento Therapeutics |
27.07.23 · globenewswire · Sorrento Therapeutics |
05.07.23 · globenewswire · Sorrento Therapeutics |
26.06.23 · globenewswire · Sorrento Therapeutics |
13.06.23 · globenewswire · Sorrento Therapeutics |
05.06.23 · globenewswire · Sorrento Therapeutics |